This finding suggested that measurement of phospho-T356RB1 might strongly predict RB1 activity and given the crucial role of RB1, pT356RB1 levels may be informative in terms of patient outcome for cases of HPV-negative SCCHN. The gene discussed is RB1; the disease is head and neck squamous cell carcinoma.